While peer review and replication of results have long been a hallmark of high-quality research, the scrutiny of results has intensified in recent years, particularly in situations where the technology is bound for licensing or acquisition. Competition, technological challenges, economic pressure, and rare but high-profile cases of fraud are all contributing to this phenomenon.

Strategic Partnerships: How to Select and Optimize Relationships with Other Businesses The path to market for life sciences technologies can be long and challenging, but working with the right strategic partner can significantly impact the timeline in a positive way. “Strategics,” as they’re often called, may also turn out be a crucial source of funding or [...]

It may seem odd to think about departing a business you’ve recently started, but it’s never too early to begin thinking about if, when, and how you will exit. Do you expect the company will remain modest in size, be listed on a stock exchange, or something in between? Join the live webinar to listen [...]

https://www.youtube.com/watch?v=YjIzYD7mEgI Are you aware that the Commonwealth of Pennsylvania, as well as some county and local governments, may have tax credit and funding programs available to you? Or that foundations often provide support for disease-specific or life sciences technology development? One of them just might be right for you! Moderator: • Michael McCann, President [...]

REGISTER HERE

What You Need to Know about Angel Investment and Seed-Stage Venture Funding You’ve invested both cash and sweat equity into your emerging life sciences company, right? It’s likely you’ve received grant funding, too, as well as investment from “friends and family.” Nevertheless, you’re going to need more money to reach the milestones that tend to [...]

Best Practices for Faculty and Founders Researchers and would-be life sciences company founders, this panel is designed especially for you! Learn directly from technology transfer professionals at some of Pennsylvania’s premier institutions how, when and why to work with technology transfer offices to optimize the power of invention. Topics to be explored include: Tips for [...]

How do you turn great science into a great business? By pooling the efforts and expertise of talented individuals. During this panel we'll explore how to: Identify and prioritize the skills and expertise needed to grow a life science business Strategies for finding and attracting the right hires  Creative approaches to tapping professional expertise  Regional [...]

Making Sense of a Complex Landscape Developers of Medical Diagnostics face a complex and rapidly evolving intellectual property landscape. Successful commercialization of discoveries in this space requires an understanding of: The pathway from biomarker to diagnostic tool How IP aligns with clinical needs Expectations of commercialization partners This month’s panel features a combination of legal, [...]

Tips for Selecting and Working with a Contract Research Organization (CRO) CROs and related businesses known as CMOs and CDMOs are a critical part of the life sciences ecosystem, offering everything from laboratory services for early-stage companies operating virtually to post-marketing surveillance for global pharmaceutical companies and everything in between. Not all are created alike, [...]

The Light at the End of the Tunnel: Preparing for an Exit Strategy One of the most important decisions in a startup life cycle is determining the appropriate time for an exit strategy. From mergers & acquisitions to IPOs, the best exit strategies will require a careful assessment of the startup’s strengths, circumstances and various [...]